Vault-13

DRUGS MADE IN AMER ACQ II CO DMIIU

UNIT 09/16/2030 · Unit · CUSIP G2851K120

11 institutional holders -3 vs Q1 2026
3,445,0393.4m shares reported held*
$35.0mreported value*
0 new 1 added 3 reduced 3 sold out net sold ≈ $9.0m (-906.9k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $10.16.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

0255075Q3 25: 75Q4 25: 30Q1 26: 14Q2 26: 1111Q3 25Q4 25Q1 26Q2 26
Numbers
QuarterHolders
Q3 202575
Q4 202530
Q1 202614
Q2 202611

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
1000100Q4 25: 10 bought or addedQ4 25: 58 cut or sold outQ4 25Q1 26: 2 bought or addedQ1 26: 21 cut or sold outQ1 26Q2 26: 1 bought or addedQ2 26: 6 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q4 20251058
Q1 2026221
Q2 202616

Biggest buyers

UBS Group AG Added +2+2

Biggest sellers

TIG Advisors, LLC Sold out -500,000-500.0k
Kepos Capital LP Sold out -210,000-210.0k
Clear Street Group Inc. Reduced -158,558-158.6k
Rangeley Capital, LLC Reduced -23,061-23.1k
ROBINSON CAPITAL MANAGEMENT, LLC Sold out -15,000-15.0k
HRT FINANCIAL LP Reduced -275-275

Insider purchases and sales since 1 Apr 2026

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
101Q4 24: 0 buyingQ4 24: 0 sellingQ1 25: 0 buyingQ1 25: 0 sellingQ1 25Q2 25: 0 buyingQ2 25: 0 sellingQ3 25: 1 buyingQ3 25: 1 sellingQ3 25Q4 25: 0 buyingQ4 25: 0 sellingQ1 26: 0 buyingQ1 26: 0 sellingQ1 26Q2 26: 0 buyingQ2 26: 0 sellingQ3 26: 0 buyingQ3 26: 0 sellingQ3 26
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q4 20240—0——
Q1 20250—0——
Q2 20250—0——
Q3 20251—1——
Q4 20250—0——
Q1 20260—0——
Q2 20260—0——
Q3 20260—0——

None reported since 1 Apr 2026.

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change
1 LMR Partners LLP 0.15% of their portfolio LONDON, X0 2,000,0002.0m $20.3m $20.3m 0.15% Unchanged
2 Westchester Capital Management, LLC 0.26% of their portfolio VALHALLA, NY 502,914502.9k $5.1m $5.1m 0.26% Unchanged
3 Verition Fund Management LLC 0.02% of their portfolio GREENWICH, CT 250,000250.0k $2.5m $2.5m 0.02% Unchanged
4 BlueCrest Capital Management Ltd 0.11% of their portfolio ST HELIER, Y9 250,000250.0k $2.5m $2.5m 0.11% Unchanged
5 Walleye Capital LLC 0.00% of their portfolio NEW YORK, NY 100,000100.0k $1.0m $1.0m 0.00% Unchanged
6 L1 Global Manager Pty Ltd 0.82% of their portfolio Melbourne, C3 100,000100.0k $1.0m $1.0m 0.82% Unchanged
7 READYSTATE ASSET MANAGEMENT LP 0.04% of their portfolio CHICAGO, IL 100,000100.0k $1.0m $1.0m 0.04% Unchanged
8 HRT FINANCIAL LP 0.00% of their portfolio NEW YORK, NY 99,72599.7k $1.0m $1.0m 0.00% Reduced -275 -275
9 Rangeley Capital, LLC 0.31% of their portfolio NEW CANAAN, CT 32,55132.6k $330.7k $330.7k 0.31% Reduced -23.1k -23,061
10 Clear Street Group Inc. 0.00% of their portfolio NEW YORK, NY 8,0848.1k $82.1k $82.1k 0.00% Reduced -158.6k -158,558
11 UBS Group AG 0.00% of their portfolio ZURICH, V8 1,7651.8k $17.9k $17.9k 0.00% Added +2 +2